COVID-19 residual symptoms and adverse drug reactions after oral antiviral therapy in the Singapore primary care setting

Ann Acad Med Singap. 2024 Dec 26;53(12):762-764. doi: 10.47102/annals-acadmedsg.2024200.

Authors

Jia Qi Yeo¹, Poh Ching Tan¹, Cheryl Wei Yan Tan¹, Poay Sian Sabrina Lee²

Affiliations

¹ Department of Pharmacy, National Healthcare Group Pharmacy, Singapore.
² Clinical Research Unit, National Healthcare Group Polyclinics, Singapore.

PMID: 39748176
DOI: 10.47102/annals-acadmedsg.2024200

No abstract available

Keywords: COVID-19; SARSCoV-2; adverse drug reaction; molnupiravir; nirmatrelvir-ritonavir; paxlovid.

Publication types

Letter